<DOC>
	<DOCNO>NCT00997230</DOCNO>
	<brief_summary>The primary objective study collect epidemiological data EGFR mutation status ( M+ , M- ) population predominantly Caucasian ethnicity correlate EGFR mutation status clinico-pathological characteristic ( e.g . smoking status , sex , histology , etc ) . In particular , study aim determine frequency EGFR M+ lung cancer patient clinico-pathological characteristic commonly associate EGFR mutation positivity ( i.e. , smoker , men , non-adenocarcinoma ) .</brief_summary>
	<brief_title>Epidemiological Scientific Evaluation EGFR Mutation Status Patients With Newly Diagnosed Locally Advanced</brief_title>
	<detailed_description>An NIS Registry Epidemiological Scientific evaluation EGFR mutation status patient newly diagnose locally advanced metastatic NSCLC ( stage IIIB/IV non-small cell lung cancer )</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically confirm locally advanced metastatic NSCLC ( stage IIIB/IV ) . Mixed histology small cell nonsmall cell lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>EGFR mutation , newly diagnose NSCLC , locally advanced metastatic NSCLC</keyword>
</DOC>